Babraham Appoints Wakelam

The UK’s Biotechnology and Biological Sciences Research Council announced a couple of days ago that it had appointed Michael Wakelam, currently of the University of Birmingham, to be its director as of January 1 next year.

Written byStephen Pincock
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The UK’s Biotechnology and Biological Sciences Research Council (BBSRC) announced a couple of days ago that it had appointed Michael Wakelam, currently of the University of Birmingham, to be its director as of January 1 next year. Wakelam looks to be a good match for the institute, which conducts research and training in the mechanisms of cell communication and gene regulation. His own area of expertise is cell signaling, with a focus on the regulation of signalling pathways in normal and cancer cells and in inflammatory responses.

“I look forward to the stimulation of leading such a successful and focused centre, both in terms of the science and the increasingly successful interactions with biotech businesses at the Babraham campus,” he said.

Unsurprisingly, the BBSRC’s notice made no mention of the racial discrimination case that been brought against the BBSRC last year over the selection process for the director’s job. In ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies